Lonza Group AG
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of LONN-SW would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1999) — listing | $250,255 6.2× | $357,791 6.1× |
| Year 6 (2004) | $179,880 5.3× | $258,971 5.3× |
| Year 11 (2009) | $114,101 4.4× | $165,836 4.3× |
| Year 16 (2014) | $39,640 2.1× | $57,789 2.1× |
| Year 21 (2019) | $11,841 1.1× | $17,335 1.1× |
| Year 26 (2024) | $3,447 1.0× | $5,110 1.0× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
Basel, Switzerland
Popular scenarios with LONN
For illustration only — not investment advice. Past performance is not indicative of future results.